Atlas Trials

Safety Study of RMJH-111b to Treat Essential Hypertension

Clinical trial NCT02822222 · COMPLETED

Trial details

NCT number
NCT02822222
Sponsor
RMJ Holdings, LLC
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Essential Hypertension
Start date
2016-06-10
Primary completion
2016-07-07
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.